These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction. Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803 [TBL] [Abstract][Full Text] [Related]
5. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659 [TBL] [Abstract][Full Text] [Related]
6. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review. Benden C; Haughton M; Leonard S; Huber LC J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986 [TBL] [Abstract][Full Text] [Related]
7. Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation. Robinson PD; Spencer H; Aurora P J Heart Lung Transplant; 2015 Aug; 34(8):1082-8. PubMed ID: 25979626 [TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813 [TBL] [Abstract][Full Text] [Related]
9. Single lung transplantation for chronic obstructive pulmonary disease: pulmonary function and impact of bronchiolitis obliterans syndrome. Bjørtuft O; Geiran OR; Fjeld J; Skovlund E; Johansen B; Boe J Respir Med; 1996 Oct; 90(9):553-9. PubMed ID: 8984530 [TBL] [Abstract][Full Text] [Related]
10. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Meyer KC; Raghu G; Verleden GM; Corris PA; Aurora P; Wilson KC; Brozek J; Glanville AR; ; Eur Respir J; 2014 Dec; 44(6):1479-503. PubMed ID: 25359357 [TBL] [Abstract][Full Text] [Related]
11. Validation of a post-transplant chronic lung allograft dysfunction classification system. Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199 [TBL] [Abstract][Full Text] [Related]
12. A new classification system for chronic lung allograft dysfunction. Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027 [TBL] [Abstract][Full Text] [Related]
13. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction. Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441 [TBL] [Abstract][Full Text] [Related]
15. Impact of Forced Expiratory Volume in 1 Second (FEV1) and 6-Minute Walking Distance at 3, 6, and 12 Months and Annually on Survival and Occurrence of Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation. Fakhro M; Ingemansson R; Algotsson L; Lindstedt S Ann Transplant; 2017 Sep; 22():532-540. PubMed ID: 28871078 [TBL] [Abstract][Full Text] [Related]
16. Current views on chronic rejection after lung transplantation. Verleden GM; Vos R; Vanaudenaerde B; Dupont L; Yserbyt J; Van Raemdonck D; Verleden S Transpl Int; 2015 Oct; 28(10):1131-9. PubMed ID: 25857869 [TBL] [Abstract][Full Text] [Related]
17. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation. Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885 [TBL] [Abstract][Full Text] [Related]
18. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder? Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078 [TBL] [Abstract][Full Text] [Related]
19. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Lama VN; Murray S; Lonigro RJ; Toews GB; Chang A; Lau C; Flint A; Chan KM; Martinez FJ Am J Respir Crit Care Med; 2007 Jun; 175(11):1192-8. PubMed ID: 17347496 [TBL] [Abstract][Full Text] [Related]
20. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant. Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]